BeOne Medicines
ONC
#629
Rank
โ‚น3.483 T
Marketcap
โ‚น31,480
Share price
-0.86%
Change (1 day)
62.08%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

EPS for BeOne Medicines (ONC)

EPS in 2025 (TTM): โ‚น59.27

According to BeOne Medicines's latest financial reports the company's current EPS (TTM) is โ‚น58.64. In 2024 the company made an earnings per share (EPS) of -โ‚น562.90.

EPS history for BeOne Medicines from 2015 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น59.27-110.53%
2024-โ‚น562.90
2022-โ‚น1,75928.21%
2021-โ‚น1,372-19.96%
2020-โ‚น1,71420.81%
2019-โ‚น1,41931.52%
2018-โ‚น1,079417.57%
2017-โ‚น208.45-37.16%
2016-โ‚น331.74158.95%
2015-โ‚น128.11

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
-โ‚น21.65-136.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-โ‚น85.70-246.15%๐Ÿ‡บ๐Ÿ‡ธ USA